FdaApplication

ANDA 203079

Back to search

Identifiers

Properties

PropertyValue
applicant_nameHIKMA PHARMACEUTICALS USA INC
application_typeANDA
approval_date2023-04-19

Products (1)

ProductActive ingredientStrengthDosage form
CISATRACURIUM BESYLATECISATRACURIUM BESYLATEEQ 2MG BASE/MLINJECTABLE;INJECTION

1 product